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Abstract
Spinal muscular atrophy (SMA) is caused by low levels of survival motor neuron (SMN), a multifunctional
protein essential for higher eukaryotes. While SMN is one of the most scrutinized proteins associated with
neurodegeneration, its gender-specific role in vertebrates remains unknown. We utilized a mild SMA model
(C/C model) to examine the impact of low SMN on growth and development of mammalian sex organs. We
show impaired testis development, degenerated seminiferous tubules, reduced sperm count and low fertility
in C/C males, but no overt sex organ phenotype in C/C females. Underscoring an increased requirement for
SMN expression, wild type testis showed extremely high levels of SMN protein compared to other tissues.
Our results revealed severe perturbations in pathways critical to C/C male reproductive organ development
and function, including steroid biosynthesis, apoptosis, and spermatogenesis. Consistent with enhanced
apoptosis in seminiferous tubules of C/C testes, we recorded a drastic increase in cells with DNA
fragmentation. SMN was expressed at high levels in adult C/C testis due to an adult-specific splicing switch,
but could not compensate for low levels during early testicular development. Our findings uncover novel
hallmarks of SMA disease progression and link SMN to general male infertility.
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Severe impairment of male 
reproductive organ development in 
a low SMN expressing mouse model 
of spinal muscular atrophy
Eric W. Ottesen1,*, Matthew D. Howell1,*, Natalia N. Singh1, Joonbae Seo1, 
Elizabeth M. Whitley2 & Ravindra N. Singh1
Spinal muscular atrophy (SMA) is caused by low levels of survival motor neuron (SMN), a multifunctional 
protein essential for higher eukaryotes. While SMN is one of the most scrutinized proteins associated 
with neurodegeneration, its gender-specific role in vertebrates remains unknown. We utilized a mild 
SMA model (C/C model) to examine the impact of low SMN on growth and development of mammalian 
sex organs. We show impaired testis development, degenerated seminiferous tubules, reduced sperm 
count and low fertility in C/C males, but no overt sex organ phenotype in C/C females. Underscoring 
an increased requirement for SMN expression, wild type testis showed extremely high levels of SMN 
protein compared to other tissues. Our results revealed severe perturbations in pathways critical to 
C/C male reproductive organ development and function, including steroid biosynthesis, apoptosis, 
and spermatogenesis. Consistent with enhanced apoptosis in seminiferous tubules of C/C testes, we 
recorded a drastic increase in cells with DNA fragmentation. SMN was expressed at high levels in adult 
C/C testis due to an adult-specific splicing switch, but could not compensate for low levels during early 
testicular development. Our findings uncover novel hallmarks of SMA disease progression and link SMN 
to general male infertility.
Spinal muscular atrophy (SMA) is a leading genetic cause of infant mortality1 and results from deletion and/
or mutation of survival motor neuron 1 (SMN1), a gene that codes for SMN protein1. A nearly identical gene, 
SMN2, cannot compensate for the loss of SMN1 due to predominant skipping of exon 7, producing SMNΔ 7, a 
truncated protein that is partially functional and highly unstable2. The severity of SMA correlates with the level 
of SMN, a multifunctional protein implicated in regulation of small nuclear heteronuclear ribonucleoprotein 
(snRNP) biogenesis, transcription, translation, stress granule formation, signal transduction and axonal transport 
of mRNA (references in Seo et al., 20133). Motor neurons are particularly sensitive to the loss of SMN, although 
reduced SMN independently affects non-neuronal tissues, including muscle4, heart5, lungs, and intestine6. SMN 
is required for male germ cell maintenance in Drosophila7, however, no parallel can be drawn with mammalian 
spermatogenesis, which occurs within the specialized microenvironment of seminiferous tubules.
Multiple mouse models recapitulating various aspects of SMA have been generated8. The Taiwanese and Δ 7 
mice, the best characterized and most widely utilized models, exhibit severe phenotypes, including early postna-
tal lethality, impaired maturation of neuromuscular junctions and overall deficient motor function1,8. However, 
due to their short lifespan, these models are not appropriate for examining the role of SMN in male reproduc-
tive organ development. The testis is unique in producing higher SMN levels due to predominant expression of 
full-length SMN2 transcripts compared to all other adult tissues and organs of a mild mouse model of SMA9,10. 
Alternative splicing of several genes are switched during testicular development11. However, it is not known if 
SMN2 exon 7 undergoes a similar switch.
The recently reported SmnC/C (C/C) model expresses a reduced amount of SMN (~25–50% of WT) and dis-
plays a mild SMA-like phenotype, including peripheral necrosis, autonomic nervous system dysfunction and 
allodynia12. Here we employ the C/C mouse to examine the role of SMN in reproductive organ development. We 
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observed reduced testis size and impaired spermatogenesis in C/C mice, despite high SMN expression in testis. 
We show severe perturbations of the testicular transcriptome in young adult C/C mice, suggesting massive repro-
gramming of transcription and posttranscriptional regulation. Our results uncover a surprising shift in splicing 
regulation of various SMN2 exons during the first wave of spermatogenesis. Our findings implicate for the first 
time a role for SMN in mammalian reproductive organ development and further elucidate the complex physio-
logical role of this essential protein.
Results
C/C males exhibit small testes with impaired spermatogenesis and reduced fertility. To deter-
mine the effect of low SMN on reproductive organ development, we examined wild type (WT) and C/C mice at 
postnatal day 42 (P42). At this age, mice have completed the first wave of spermatogenesis. Notably, we observed 
substantially smaller testes in C/C males even after correcting for body weight (Fig.1a–c). Testosterone is a crucial 
hormone regulating testis development, however, we observed no significant difference in serum testosterone 
between WT and C/C mice (Fig. 1d). Histological analyses of C/C testes showed heterogeneity of seminifer-
ous tubules, with evidence of degeneration, including vacuolization, multinucleated bodies and sloughed cells 
(Fig. 1e, right panel). We assessed the health of seminiferous tubules using an established scale13. The average 
score for C/C testes indicated an overall reduction in post-meiotic cells and disrupted spermatogenesis (Fig. 1f). 
Histology of C/C epididymis showed a lack of or reduced number of spermatozoa in tubules of all regions 
(Fig. 1g). Consistently, we observed a ~10-fold reduction in epididymal sperm count in P60 C/C males compared 
to WT males (Fig. 1h), indicating that spermatogenesis was impaired, but not globally arrested.
Unlike testes, C/C female reproductive organs appeared normal, although variable in size (Fig. 2a). Gross 
uterus/ovaries mass was reduced for C/C females (Fig. 2b), but not after correction by total body weight (Fig. 2c). 
Beyond the gross weight difference, there were no overt histological changes in C/C uterus and ovaries (Fig. 2d). 
Ovaries from females of both genotypes exhibited follicles with oocytes in various stages, and the corpus luteum 
and uterus appeared normal (Fig. 2d).
In order to evaluate the fertility of C/C mice, we set up breeding cages with different combinations of WT, 
C/C, and heterozygous (C/+ ) mice (Supplementary Table 1) and followed them for ninety days. WT males all 
sired multiple litters of pups (Supplementary Table 1). In contrast, only two of the eight C/C males sired a litter: 
one male paired with a WT female and another paired with a C/C female (Supplementary Table 1). Both sired 
only one litter and neither female appeared pregnant again after giving birth. The fact that two C/C males were 
able to sire at least one litter despite very low sperm count suggests no debilitating defect in sperm motility 
and/or fertilization. In contrast, C/C females were fertile; over a 90 day period, there was no significant difference 
in number of litters born (Fig. 2e) or litter size (Fig. 2f) compared to heterozygote females (Supplementary Table 
1).
High levels of SMN are expressed in C/C testis. The recently developed multi-exon-skipping detection 
assay (MESDA) determines the relative abundance of all SMN splice isoforms in a single reaction14. We employed 
MESDA on various tissues of C/C mice. Consistent with previous reports9,10, testis emerged as the only tissue 
to have full-length SMN2 transcript as the major product (Fig. 3b), and the only tissue to express appreciable 
amounts of full-length product from the hybrid Smn gene (Fig. 3c). Supporting a heightened requirement for 
SMN in testis, we confirmed that there was a very high expression of SMN protein in WT testis compared to all 
other tissues, including brain and spinal cord (Fig. 3d). When we compared SMN levels in C/C and WT tissues, 
we observed a ~50% reduction in brain, liver, heart, and uterus/ovaries of C/C mice (Fig. 3e–h). However, there 
was no difference in SMN protein between WT and C/C testes (Fig. 3h). Although consistent with the results of 
MESDA, the lack of SMN reduction in testis was at odds with the drastic phenotype and may indicate one or more 
of the following: (i) SMN expression is reduced at an earlier developmental stage which causes defects at later 
time points; (ii) the cell types with low SMN expressions are already lost by P42; (iii) or the testis phenotype is an 
indirect result of low SMN levels in other tissues, such as the nervous system.
C/C testis transcriptome is dramatically altered. We performed deep sequencing of the testis as well 
as brain and liver transcriptome of WT and C/C mice (Supplementary Table 2) to characterize molecular changes 
in these tissues (Sequence Read Archive accession number SRP062636). During initial quality control, we deter-
mined that one sample derived from a C/C testis was an outlier; it was removed from all further analysis. Using 
the remaining replicates, we identified 3,724 differentially expressed genes using a false discovery rate (FDR) 
cutoff of 0.05, with 2,186 genes upregulated and 1,538 downregulated in C/C testes (Fig. 4a). In contrast, very few 
genes showed aberrant expression in C/C brain and liver (Fig. 4a) Summary statistics for the 50 most significantly 
upregulated and downregulated genes are given in Supplementary Tables 3 and 4.
Several Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and gene ontology (GO) terms were 
disproportionately affected in C/C testes. The top 25 enriched pathways in C/C testis are shown in Fig. 4b, 
including apoptosis, cell and extracellular matrix interaction (potential problems with tissue organization and/
or integrity) and cardiomyopathy and smooth muscle contraction (potential problems with blood flow and/or 
transport of spermatozoa to epididymis). GO term analysis was somewhat less informative (Supplementary Figs. 
S1–S3), although several GO terms associated with spermatogenesis were enriched in the list of downregulated 
genes (Supplementary Fig. S3). We also examined expression of several genes that are previously identified to 
be mutated in cases of oligospermia15; of the fourteen genes, six (H19, Klhl10, Prm1, Shbg, Tssk4, and Vasa) 
showed significantly altered expression in C/C testes (Supplementary Fig. 4). Aside from pathways and genes, 
we also detected changes suggesting altered enrichment of genes in specific groups of testicular cell types16. 
Consistent with our histological analyses, genes that are highly expressed in somatic and early spermatogenic 
cell types were strongly enriched, and genes expressed in late spermatocytes and spermatids were found to be 
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downregulated (Fig. 4c). We also examined the relative expression of individual markers specific for testicular cell 
types (Supplementary Fig. 5). These results suggest extensive cell death of pachytene spermatocytes and/or arrest 
of zygotene spermatocytes in C/C testes.
We independently validated the results of RNA-Seq by quantitative PCR (QPCR) of > 50 candidate genes 
(full list in Supplementary Table 5). There was a strong correlation (r2 = 0.8376) between RNA-Seq and QPCR 
Figure 1. Male reproductive organs and functions are abnormal in P42 C/C mice. (a) Representative 
photograph of WT (left) and C/C (right) male reproductive organs, including testis, epididymis and 
epididymal fat pad. Scale bar represents 5 mm. (b) Gross testis mass. (c) Relative testis mass was determined 
by dividing gross testis mass by total body weight (n = 10 WT and 6 C/C mice). (d) Serum testosterone level 
determined by ELISA (n = 5 mice per genotype). (e) Representative H&E stained testis cross-sections. Circled 
numbers represent score of each tubule based upon a 10 point system that assesses morphology13. Damage 
and degeneration, including vacuolization (black arrowheads), multinucleated bodies (red arrowheads) and 
sloughed tissue (blue arrowheads) are indicated. Scale bars represent 50 μ m. (f) Average seminiferous tubule 
scores for WT and C/C testes. Each point represents a single mouse (n = 10 WT and 6 C/C mice). Pie charts 
below data points represent the distribution of all seminiferous tubule scores for WT and C/C males. The legend 
underneath indicates the color for each score. (g) Representative H&E stained cross sections of epididymal 
regions. The cartoon to the right indicates the location of each region. Scale bars represent 50 μ m. (h) Total 
epididymal sperm count from P60 males (n = 8 WT and 6 C/C mice). (Statistical significance: ***p < 0.001).
www.nature.com/scientificreports/
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results (Fig. 4d). Five genes in particular (Lamb2, Ddr1, Apoe, Cpe, SerpinG1) were highly upregulated, ranging 
from ~1.5–4 fold above WT (Fig. 4e). We also tested four genes, which were predicted by RNA-Seq to be highly 
downregulated. Of these, Npy, a gene that codes for neuropeptide Y pro-protein, was strongly downregulated, 
though Npy expression was highly variable. The other three genes (Tppp2, Ppp2r2b, and Oaz3) all trended down-
ward, but the decrease was only statistically significant for Tppp2 (Fig. 4f). Of the five steroid biosynthesis genes 
(Lss, Msmo1, Dhcr7, Lipa, and Dhcr24) that we tested, all were significantly upregulated (Fig. 4g). In addition, we 
tested 5 genes participating in spermatogenesis; however, although all trended downward, we observed a signif-
icant decrease only in Gapdhs (Fig. 4h). Many genes involved in axon guidance were affected; of these, the five 
most strongly upregulated were Ephb1, Efnb1, Ntn3, Cxcl12, and Slit3 (Fig. 4i). Ppp3r2 was the only gene in this 
category that was significantly downregulated (Fig. 4i). Several long non-coding RNAs (lncRNAs) had altered 
expression levels in C/C testes. Of the five that were validated, Meg3, Neat1, and Malat1 were strongly upregulated 
(Fig. 4j). We examined the expression of all the Gemins, which code for proteins associated with SMN complex 
assembly and function. Only Gemin4 was significantly downregulated (Fig. 4k).
Apoptotic pathways are dysregulated in C/C testes. Our RNA-Seq results suggested significant dys-
regulation of the apoptotic pathways in C/C testes (Fig. 4b), with much fewer changes in brain and liver (Fig. 5a). 
We confirmed by QPCR that a number of pro- (Bax, Casp7, Casp8, Casp9, Capn2, Aifm1) and anti- (Bcl3, Akt) 
Figure 2. P42 female C/C reproductive organs exhibit minimal abnormalities. (a) Representative 
photograph of WT (top) and C/C (bottom) uterus and ovaries. Scale bar represents 5 mm. (b) Gross uterus and 
ovaries mass. (c) Relative uterus and ovaries mass was determined by dividing gross uterus and ovaries mass 
by total body weight (n = 10 WT and 7 C/C mice). (d) Representative H&E stained cross-sections of ovary 
and the endometrium. Follicle (F) and corpus luteum (CL) are indicated on ovary micrographs. Scale bars 
represent 100 μ m. (e–f) Fertility of heterozygous (n = 11) and C/C (n = 3) female mice. Females were paired 
in monogamous breeding cages with either a heterozygote or WT male. The average number of litters born 
over ninety days (e) and the average litter size for heterozygote or C/C mothers (f) were recorded. (Statistical 
significance *p < 0.05).
www.nature.com/scientificreports/
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apoptotic genes were significantly upregulated in C/C testis (Fig. 5b), but not in brain (Fig. 5c) or liver (Fig. 5d). 
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, which detects DNA frag-
mentation usually associated with apoptosis, revealed a ~3-fold increase in the percentage of seminiferous 
tubules with at least one TUNEL-positive cell (Fig. 5e,f). We also observed a significant increase in the average 
number of TUNEL-positive cells per tubule (Fig. 5g). For WT testes, TUNEL-positive cells were predominantly 
spermatocytes and the remaining were spermatogonia (Fig. 5h). These WT TUNEL-positive cells most likely 
Figure 3. High levels of SMN are expressed in C/C testis. (a) Diagram of the SmnC locus. Endogenous mouse 
Smn is interrupted 2,195 bp into intron 6 and replaced with the equivalent human SMN2 sequence through 
the 3′ -UTR, followed by 42 kb human SMN2 genomic sequence. Exon lengths appear above colored boxes and 
intron lengths appear below lines. This transgene results in two genes, hybrid Smn and WT SMN2. MESDA14 
was used to determine all splice variants for SMN2 (b) and Smn hybrid (c) in various tissues. Band identities are 
given to the left of the lanes, where Δ indicates the lack of specific exon(s). Tissue abbreviations are indicated in 
panel (d). Additional abbreviations: E, exon; In, intron; UTR, untranslated region; FL, full-length. (d) Western 
blots of SMN, Gemin2 and Actin (top three panels) expression in adult WT tissue, and accompanying silver 
stain to confirm approximately equal loading. Samples were prepared by dissecting tissues from 3 WT males 
and immediately grinding them together in liquid nitrogen. 5 μ g of protein was loaded for silver staining and 
7.5 μ g was loaded for western blotting. Tissue abbreviations appear to the right. (e–h) Representative SMN and 
Actin western blots from male (M) and female (F) brain (e), heart (f), liver (g), and testis and uterus/ovaries 
(U/O) (h). For (e–h), n = 3 or 4 mice per genotype. (Statistical significance: *p < 0.05).
www.nature.com/scientificreports/
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Figure 4. RNA-Seq reveals drastic alterations in C/C testis transcriptome. (a) MA plots for testis (top), brain 
(middle) and liver (bottom). The y-axis depicts log2 fold change (LFC) in gene expression in C/C compared 
to WT, and the x-axis depicts the mean read count for each gene between all samples. Each dot represents one 
gene, with red dots representing genes with significantly altered expression values (Benjamini and Hochberg 
(B + H) adjusted p value < 0.05). (b) KEGG pathways enriched for genes with altered expression levels in C/C 
testis. The length of each bar represents the B + H adjusted p value of enrichment for each pathway. The number 
at the top of each bar represents the number of genes participating in each pathway with significantly altered 
expression. (c) Percentage of genes upregulated (white bars) or downregulated (black bars) in C/C testes that 
are classified as being primarily expressed in certain testicular cell types. Abbreviations used: spermatogonia 
(SG), spermatocytes (SC). (d) LFC in C/C testes of several candidate genes as measured by RNA-Seq (y values) 
www.nature.com/scientificreports/
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represented damaged germ cells that must be eliminated before meiotic division into abnormal spermatids17. 
Most TUNEL-positive cells in C/C testes were spermatocytes, similar to WT, but we also observed TUNEL stain-
ing of a small number of Sertoli cells and round spermatids (Fig. 5h). Since depletion of Sertoli cells can have 
drastic consequences for germ cell health18, increased apoptosis in spermatogonia and spermatocytes may be 
due to dysfunction of Sertoli cells, or vice versa. Immunostaining for cleaved caspase 3, a marker for apoptosis, 
revealed positive spermatogonia (Fig. 5i, panel I), spermatocytes (panel II) and multinucleated bodies (panel 
III) in C/C testes, but a lack of cleaved caspase 3-positive cells in WT testes (panel IV). This observation further 
underscores that apoptosis is dysregulated in C/C testes.
SMN2 undergoes splicing switch during testicular development. The first wave of spermatogenesis 
in mice occurs from P10 to P35. This process is characterized by synchronous transitions from one cell type to 
another and marked by predictable changes in the testis transcriptome16,19 (Fig. 6a). We employed MESDA to 
capture splicing of SMN2 exons during the first wave of spermatogenesis. In particular, we compared the splicing 
pattern of SMN2 in P7 testes, when spermatogonia are the predominant germ cell type, with testes undergoing 
meiosis (P10, P12 and P18), and near the end (P30) and after completion of the first wave of spermatogenesis 
(P42). We observed a dramatic shift in SMN2 exon 7 splicing from overwhelming skipping at P7 to higher inclu-
sion at P18 and later (Fig. 6b). We also observed increased skipping of exon 5 and decreased co-skipping of exons 
3 and 7 at later time points (Fig. 6b). With regards to hybrid Smn (Fig. 3a), there was an increase in exon 7 inclu-
sion starting at P18 (Fig. 6c). Our findings represent the first report of a shift in SMN2 splicing pattern during tes-
tis development. Increased SMN2 exon 7 inclusion coincided with the completion of initial stages of meiosis and 
likely occurred in spermatocytes and spermatids. SMN2 transcripts of somatic testicular cells and spermatogonia, 
which are more highly represented at early time points were likely still dominated by exon 7 skipped forms, and 
therefore likely had a deficiency in SMN protein expression.
Previous evidence suggested that hnRNP Q and Tra2β are important for SMN2 exon 7 inclusion in testes9,10. 
Thus, we examined whether changes in expression of splicing factors known to regulate SMN2 exon 7 splicing 
coincided with the changes in SMN2 splicing during testis development. hnRNP A1 and Q protein levels were 
highest at P7 and dropped during testis development, dramatically so in the case of hnRNP A1 (Fig. 6d). Since 
hnRNP Q was expressed at relatively low levels at P18 and P30, when SMN2 exon 7 inclusion increased, it likely 
did not play a role in the splicing switch. hnRNP A1, however, is a known negative regulator of SMN2 exon 7 
inclusion, so its low expression in later time points is consistent with the change in exon 7 splicing. Tra2β was 
expressed at the highest levels at P18 and P30, when SMN2 exon 7 inclusion is highest, followed by a decrease at 
P42 (Fig. 6d). hnRNP A2/B1, a negative regulator of SMN2 exon 7 inclusion, had a nearly identical expression 
pattern. Overall, these data indicate that multiple splicing factors contribute to the SMN2 splicing pattern we 
observe during early stages of testicular development.
In order to further verify that SMN levels are altered during testis development, we first established baseline 
expression during the first wave of spermatogenesis using primers targeted to mouse Smn mRNA in WT testes. 
Smn expression peaked at P18 and P30 and then dropped slightly at P42 (Fig. 7a). In contrast, full-length SMN2 
expression in C/C testes dramatically increased at P18 and held steady thereafter (Fig. 7b). We next examined 
how SMN protein expression changed during testis development. In WT testes, SMN protein (derived from 
Smn) steadily increased and peaked at P30 with a slight decrease at P42 (Fig. 7c). In C/C testes, however, SMN 
protein (derived from SMN2 and hybrid Smn) was low until a marked increase at P18, peak expression at P30 
and a subsequent decrease at P42 (Fig. 7d). When SMN protein was compared between the genotypes, C/C SMN 
protein level was approximately half the WT level from P7 to P12, but by P18 there was no significant difference 
between the genotypes (Fig. 7e,f). We also examined expression of Gemin2, a protein that interacts with SMN. 
Similar to SMN, Gemin2 protein level was reduced by about half from P7 to P12 in C/C testes. Gemin2 rose to 
near WT level by P30 followed by a drop at P42 (Fig. 7e,g). This disparity in SMN and Gemin2 levels may suggest 
a deficiency of SMN functions mediated by Gemin2.
Dysregulation of alternative splicing in adult C/C testes. To confirm that critical alternative splicing 
events are affected during C/C testes development, we examined the splicing patterns of several genes known to 
undergo regulated alternative splicing during spermatogenesis. Add3 exon 14 inclusion increases during sper-
matogonia differentiation11. Both WT and C/C testes exhibited a similar increase in Add3 exon 14 inclusion, but 
at P42 there was a decrease in exon 14 inclusion in C/C compared to WT (Fig. 8a). Lrrc16a exon 38 splicing is 
somewhat complicated: pattern changes from predominant exclusion to inclusion during Sertoli cell maturation 
and spermatogonia differentiation while round spermatids exhibit predominant exclusion11. In C/C testes, exon 
38 inclusion followed a pattern similar to WT at P7 and P18, but not P10, and subtle differences emerged at P30 
and P42 (Fig. 8b). In Sertoli cells and spermatogonia, there is a mix of Picalm exon 13 inclusion and exclusion, 
while spermatocytes and round spermatids exhibit predominant exon 13 inclusion11. Splicing of Picalm was sim-
ilar for WT and C/C testes except at P42 where there was more exon 13 exclusion in C/C (Fig. 8c). Prevalence of 
a Picalm exon 13 alternative 3′ splice site was similar in WT and C/C testes (Fig. 8c).
and QPCR (x values). (e,f) QPCR showing aberrant testis expression of genes that are strongly upregulated 
(e) or downregulated (f). (g–i) QPCR for select genes involved in steroid biosynthesis (g), spermatogenesis 
(h) and axon guidance (i). (j) QPCR for expression of lncRNAs. (k) QPCR for expression of genes that encode 
members of the SMN complex. For (e–k), n = 8 mice per genotype (Statistical significance: *p < 0.05; **p < 0.01; 
***p < 0.001).
www.nature.com/scientificreports/
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Figure 5. Expression of apoptosis-related genes is disproportionally affected in C/C testes. (a) Heat map 
depicting the relative expression of every gene involved in apoptosis, as annotated by the Kyoto Encyclopedia 
of Genes and Genomes. Each colored bar indicates the LFC of expression in C/C compared to WT. The color 
scale is indicated below, with red colored bars indicating genes with lower expression in C/C and green colored 
bars indicating genes with increased expression in C/C. (b–d) Relative expression of several candidate genes 
involved in apoptosis, as measured by QPCR in testes (b), brain (c) and liver (d); n = 4 mice per genotype. 
(e) Representative micrographs from TUNEL assay showing nuclei (DAPI, blue), TUNEL signal (green) and 
merged image. Individual seminiferous tubules are noted with dashed white outline. Scale bars represent 
50 μ m. (f) Percentage of seminiferous tubules with at least one TUNEL-positive cell. (g) Average number of 
TUNEL positive cells per seminiferous tubules. (h) Percentage of TUNEL-positive cells classified by cell type, 
including Sertoli cells, spermatogonia (SG), spermatocytes (SC) and round spermatids (RS). For (f–h), n = 4 
mice per genotype. (i) Representative images of cleaved caspse 3 immunostaining. C/C testes with cleaved 
caspase 3-positive spermatogonia (panel I), spermatocytes (panel II) and multinucleated body (panel III) are 
indicated by arrowheads. WT testes showed absence of cleaved caspase 3 (panel IV). Scale bars represent 50 μ m. 
(Statistical significance: *p < 0.05; **p < 0.01; ***p < 0.001).
www.nature.com/scientificreports/
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In addition, RNA-Seq data revealed differential regulation of alternative splicing of several genes. We selected 
two such genes for validation. Wt1 is a tumor suppressor gene and essential for proper urogenital development20. 
In WT testes, Wt1 exon 5 is predominantly skipped at P7, with a gradual increase in inclusion up to P30 (Fig. 8d). 
C/C testes showed a similar pattern, but there was a decrease in exon 5 inclusion compared to WT testes at P30 
and P42 (Fig. 8d). Skipping of Sulf1 exon 21 is predicted to cause a frameshift eliminating the stop codon and 
resulting in a much longer protein. In WT testes, Sulf1 exon 21 shifted from complete inclusion at P7 to roughly 
40% at P18, then subsequently increased again (Fig. 8e). In C/C testes, exon 21 skipping remained the predomi-
nant event (Fig. 8e).
Figure 6. SMN2 and hybrid Smn mRNA splicing changes during testis development. (a) Timeline of the 
ages and estimated WT cell type distribution of seminiferous tubules of mice used for this study. The height of 
each designated region represents the estimated proportion of total number of cells in an average seminiferous 
tubule. (b,c) MESDA for SMN2 (b) and hybrid Smn (c); n = 2 mice per genotype. Isoform identities are given 
on the right side of each gel image where Δ indicates a skipped exon. Each lane is a representative example 
taken from two replicates. Lower panels show results of densitometric quantification of the most prominent 
isoforms of each gene. (d) Western blots for Tra2β , hnRNP Q, hnRNP A1, hnRNP A2/B1, and Actin during 
testis development. Equal amounts of protein from each of 3–4 C/C samples were pooled together and 15 μ g 
of protein loaded for each time point. Densitometric quantifications are given on the right. Abbreviation: SZ, 
spermatozoa.
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Gene expression of candidate genes is not affected until after puberty. Having observed the pre-
ponderance of splicing changes between P30 and P42 in C/C testes, we wanted to know whether expression of 
key genes followed a similar pattern. We tested mRNA levels throughout development of several genes that were 
strongly upregulated or downregulated (Fig. 4e–f) in C/C testes by QPCR. In WT, Apoe was expressed highest at 
P18, followed by P30 and P42, and at similar levels for all other time points. However, there was a drastic increase 
in expression at P42 in C/C testes, although levels did not pass the threshold value we set for FDR (Fig. 8f). Cpe 
was expressed at the highest level from P10 to P18, with the lowest expression at P42. In C/C testes, expression 
was significantly higher than WT at P42 (Fig. 8g). In WT, Ddr1 steadily decreased from P7 onwards. The pattern 
in C/C testes matched with WT until a drastic increase at P42 (Fig. 8h). Lamb2 expression steadily increased 
Figure 7. SMN mRNA and protein expression during testis development. (a,b) QPCR measurement of 
relative quantities of Smn transcript in WT testes (a) and FL (including both exons 5 and 7) SMN2 transcript in 
C/C testes (b) during development. Expression is calculated relative to the average expression level at P7. (c,d) 
Time course of SMN protein expression in WT (c) and C/C (d) mice. Blots shown are representative examples 
of each time point. (e) SMN, Gemin2 and Actin expression in WT and C/C testes during development for each 
age. (f) Densitometric analysis for SMN western blots shown in (e). (g) Densitometric analysis for Gemin2 
western blots shown in (e). N = 2–4 mice per genotype and age. (Statistical significance: *p < 0.05; **p < 0.01; 
***p < 0.001).
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until P18 and then fell again. In C/C, the pattern was the same with the exception that expression did not drop 
at P42. Expression in C/C was significantly lower at P7, although the absolute change in expression was small 
Figure 8. Alternative splicing and gene expression in C/C testes during spermatogenesis. Splicing patterns 
for Add3 exon 14 (a), Lrrc16a exon 38 (b), Picalm exon 13 (c), Wt1 exon 5 (d) and Sulf1 exon 21 (e) during testis 
development. The top panels are representative autoradiograms of semi-quantitative PCR. Isoforms are labeled 
to the right of each gel image. The bottom panels portray autoradiogram quantification. For (a–e), n = 2 mice 
per genotype. (f–n) QPCR expression of candidate genes during testis development, including Apoe (f), Cpe  
(g), Ddr1 (h), Lamb2 (i), SerpinG1 (j), Npy (k), Oaz3 (l), Ppp2r2b (m) and Tppp2 (n). Npy (k) is charted on 
a log10 scale due to large expression changes. For (f–n), n = 3–4 mice per genotype. (Statistical significance: 
*p < 0.05; **p < 0.01; ***p < 0.001).
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(Fig. 8i). SerpinG1 expression in WT increased slightly at P18 and then dropped steadily until P42, whereas in 
C/C expression was highly increased at this time point (Fig. 8j).
Npy expression exhibited quite large variation, both between different time points and between replicates. 
However, the average values at each time point were quite similar between WT and C/C testes, with the exception 
of P42, at which C/C exhibited a striking, though not statistically significant decrease, similar to what we observed 
before (Fig. 8k). Tppp2, Oaz3, and Ppp2r2b exhibited strikingly similar expression patterns, with very low levels 
until P18, then drastically increased at P30 and P42, coinciding with the emergence of spermatozoa. For all three 
genes, there were no differences in expression between WT and C/C testes until P42, when expression of Oaz3 
and Tppp2 was significantly reduced, and expression of Ppp2r2b trended downward (Fig. 8l–n).
Overall, none of the changes that we observed occurred until P42, after completion of the first wave of sper-
matogenesis. All the downregulated genes, with the exception of Npy, were only expressed at very low levels until 
P30, indicating that they are most likely spermatid- or spermatozoa-specific. This downregulation is consistent 
with the observation that C/C testes were generally lacking these cell types (Fig. 1). For genes upregulated in C/C 
testes, expression in WT was generally lowest at P42, except Apoe. Interestingly, expression of Apoe in C/C testes 
at P42 was higher than WT at any time point, indicating that there is a mechanism beyond developmental dysreg-
ulation causing increased expression of this gene.
Discussion
In this report, we employed the C/C mouse to evaluate for the first time the role of SMN in mammalian sex organ 
development and fertility. We observed severe impairment of male reproductive organ development character-
ized by smaller testes, widespread degeneration of seminiferous tubules, loss of post-meiotic cells, and a drastic 
reduction in male fertility in C/C mice. These surprising findings underscore a requirement for a relatively high 
level of SMN for the development and maintenance of male reproductive organs in mammals. A report published 
in 1986 implicated testis dysfunction in two mild SMA patients21, although genetic diagnoses were not available 
at that time. A subsequent report briefly mentioned unexplained clinical symptoms due to the influence of male 
sex in type 3 SMA patients22. Although the authors did not elaborate on the exact nature of the symptoms, they 
conveyed the necessity for an animal model of mild SMA to examine male specific pathology. Hence, our finding 
of a unique testicular phenotype in C/C mice fills a critical knowledge gap with respect to SMN function.
The testis has unique RNA metabolism, including transcription, splicing and 3′-end processing11,23,24. Given 
the prominent role of SMN in RNA metabolism and the presence of Gemin3, an SMN-interacting protein, in 
germ cell-specific chromatoid bodies25–27, it is not unexpected that SMN plays a critical role in testis develop-
ment and spermatogenesis. However, it was somewhat unexpected that we did not observe drastically altered 
gene expression until an adult age, when SMN expression in C/C testes reached high levels due to high inclu-
sion of SMN2 exon 7. Gemin2 has a stabilizing effect on SMN and its interaction with SMN is critical for most 
SMN functions28. Low level of Gemin2 in C/C testes at P42 is likely to impact all SMN functions dependent on 
SMN-Gemin2 interactions. A dramatic change in the transcriptome of C/C testis at P42 underscores pertur-
bations in pathways critical to spermatogenesis and testis function, including steroid biosynthesis, apoptosis, 
and spermatogenesis itself (Fig. 4). There was an enrichment of markers of interstitial cells and somatic cells 
of the seminiferous tubules and general loss of expression of genes enriched in post-meiotic cell types (Fig. 4, 
Supplementary Fig. 4). Intergenic lncRNAs and transposons expressed during meiosis are degraded through 
the Piwi-interacting RNA (piRNA) pathway in which Tudor domain-containing proteins play an essential role29. 
SMN being a tudor domain-containing protein and given the propensity of tudor domains to forge interactions 
among themselves26,30, it is possible that SMN directly or indirectly affects piRNA pathway.
It is known that lncRNAs are differentially regulated in testis, especially during spermatogenesis31,32. The most 
highly affected lncRNAs in C/C testes were Meg3, Malat1 and Neat1. Meg3 is expressed from paternally imprinted 
loci in mammals33 and is known to act as a tumor suppressor34. Malat1 functions by affecting the phosphorylation 
of splicing factors35, and Neat1 serves as a scaffold for the formation of paraspeckles in which many RNA binding 
proteins are sequestered36. All types of non-coding RNAs and untranslated regions impact the availability of RNA 
binding proteins and control the fate of mRNAs during spermatogenesis37. Altered expression of lncRNAs reveals 
a novel function of SMN in controlling the levels of freely available RNA-binding proteins in testes.
Apoptosis plays an essential role in spermatogenesis as it eliminates damaged meiotic and post-meiotic cells 
in testes17,38. SMN has anti-apoptotic properties39–41 and interacts with Bcl-2 to protect cells from Fas-mediated 
apoptosis42,43. Very low levels of SMN trigger DNA fragmentation in muscles and motor neurons of SMA 
patients44,45. Our finding of testicular defects and increase in TUNEL-positive cells in C/C seminiferous tubules 
suggests a necessity for much higher levels of SMN to prevent the dysregulation of apoptotic pathways in this 
tissue. Sertoli cells regulate germ cell survival through the Fas system; Fas ligand decorating the surface of Sertoli 
cells interacts with Fas present on germ cells46. Sertoli cells are the major cell type in testes until P1819, the time 
during which SMN is most strongly reduced in C/C testes. Since SMN modulates Fas-mediated apoptosis, low 
SMN in Sertoli cells could disrupt the normal regulation of this process. Further, low SMN causes defects in 
snRNP assembly and expression levels25, resulting in accumulation of the aberrantly spliced mRNA isoforms, a 
condition to which Sertoli cells are particularly sensitive46,47. SMN has also been implicated in the resolution of 
double-stranded breaks requiring expression of functional H2AX48. Hence, increased TUNEL staining in C/C 
testes could be due to an increase in the unresolved double-stranded breaks arising from meiotic recombination.
Substantial downregulation of mRNA encoding neuropeptide Y proprotein suggests possible denervation of 
C/C testes and is likely a downstream effect of the low levels of SMN at the early stages of testicular development. 
Supporting this argument, SMN-independent defects leading to mild SMA display abnormal male reproductive 
organ development and defective spermatogenesis. The most notable among these is the mutations in Vps54 
gene leading to a motor neuron disease similar to mild SMA and defects in male reproductive organ develop-
ment49. Plastin 3 coded by PLS3 is a protective modifier of SMA caused by the loss of SMN150. Interestingly, the 
www.nature.com/scientificreports/
13Scientific RepoRts | 6:20193 | DOI: 10.1038/srep20193
protective effect of Plastin 3 is not fully penetrant and appears to be specific to females. A recent study in rat testis 
implicates the role of Plastin 3 in spermatogenesis51. We did not observe aberrant expression of Vps54 or Pls3 
genes in C/C testis, excluding a direct role of these genes in testicular defects in C/C mice. However, our results 
combined with the above findings suggest an overlapping pathway of neurodegeneration and male reproductive 
organ development.
About 50% of male infertility cases, affecting >5% of the population worldwide, are caused by genetic abnor-
malities15,52. More than 20% of these cases represent nonobstructive azoospermia (NOA) in which semen con-
tains little or no sperm15,53. A genome-wide association study (GWAS) reported in 2012 linked only 6 genes 
to male fertility traits54, none of which were linked to pre-mRNA splicing, which is uniquely regulated during 
spermatogenesis. However, a GWAS conducted on Chinese men focused on serine-arginine (SR) protein-coding 
genes and found a strong correlation between NOA and mutations in SFRS9, encoding SR protein SRp30c55. 
Incidentally, SRp30c regulates SMN levels by promoting inclusion of exon 7 during pre-mRNA splicing56. Other 
studies provide additional evidence supporting the role of SMN in spermatogenesis. For example, the transcrip-
tion factor SP1 is predicted to modulate SMN levels in both mouse and humans57. A critical role for SP1 in mouse 
male germ cell development has been previously described58. Further, a recent study suggested that PRMT5, 
which plays an essential role in assembly of spliceosomal snRNPs along with SMN27, is required for germ cell 
survival during spermatogenesis in mice59. Finally, upregulation of SMN upon activation of phosphatidylinositol 
3-kinase (PI3K)/AKT and its positive impact on disease phenotype of severe SMA has been demonstrated60. 
Abrogation of PI3K/AKT pathway has been shown to affect spermatogenesis but not oogenesis61. Our finding of a 
reproductive phenotype and loss of fertility in C/C males, but not females, are consistent with those observations. 
Incidentally, several human studies have revealed fewer females than males afflicted with the milder forms of 
SMA62–64. Given these findings, it is rather expected that SMN plays a critical role in testis development and male 
germ cell survival in mammals.
Humans are unique in harboring SMN2, a gene whose function is still unknown. Generally, SMN2 is con-
sidered to be dispensable for survival, since enough SMN could be generated from SMN1. Our findings provide 
a strong rationale that the preservation of SMN2 during evolutions of humans was driven by the heightened 
requirement of SMN in male reproductive organ development. A very specific splicing switch of SMN2 to ele-
vate SMN levels in adult testis in humans appears to be part of a fine regulatory mechanism that remains to be 
further understood. The presence of SMN2 in SMA patients carries profound significance due to its ability to 
serve as a promising therapeutic target. Several pre-clinical studies employing SMN2-containing severe mouse 
models of SMA have shown extraordinary survival benefits3. However, gender-specific efficacy of drugs and 
reproductive phenotype of severe SMA mice that survive much longer upon treatment, remain unknown. Lack 
of gender-specific data in pre-clinical studies in neurodegenerative diseases has been cited as one of the major 
sources of misinterpretations and faulty conclusions65. Our findings validate those concerns and provide a reper-
toire of histological and molecular markers that could be employed for the careful monitoring of male reproduc-
tive organ health as an essential component of drug development process for SMA.
Materials and Methods
All methods were performed in accordance with the approved biosafety and radiation safety guidelines of Iowa 
State University (ISU), adhering to the federal and state guidelines. All animal experiments were carried out 
in accordance with the approved protocols by the Institutional Animal Care and Use Committee (IACUC) of 
ISU, adhering to the guidelines of American Veterinary Medical Association (AVMA), United States Health and 
Human Services (US HHS), United States Department of Agriculture (USDA) and State of Iowa.
Mice. Mice heterozygous for the C allele12 (SmnC/+) on the C57BL/6 background were purchased from Jackson 
Laboratory (stock number 008714). Breeding cages with one male and one female heterozygote were set up and 
maintained at ISU to generate the mice used for all experiments. This cross generated WT mice (Smn+/+) and C/C 
mice (SmnC/C). Pups were genotyped and sacrificed at the appropriate ages. Unless otherwise stated, all experi-
ments were carried out at P42.
Fertility assessment. Monogamous breeding pairs were established between three- to five-month-old mice 
and followed for ninety days. Once established, females were checked every twelve hours for a vaginal plug for 
the first five days. The number of litters and number of pups per litter were recorded. After ninety days mice were 
weighed, euthanized and tissues were collected. Testis mass and epididymal sperm count were determined for 
male mice.
Epididymal sperm counting. P60 WT and C/C mice were anesthetized with isoflurane and killed by cer-
vical dislocation. The epididymides were dissected, minced with a fresh number 10 disposable scalpel and placed 
in 3 ml Dulbecco’s Modified Eagles’ Medium supplemented with 10% fetal bovine serum (Life Technologies) for 
15 minutes at 37 °C. After incubation, the cell suspension was triturated 15 times. Dilutions of the sperm were 
prepared in water and incubated at room temperature for two minutes. The diluted cell suspension was loaded on 
a haemocytometer, allowed to settle, and only sperm with a head and tail were counted.
Tissue collection. For RNA and protein isolation, P7, P10, P12, P18 and P30 WT and C/C mice were deeply 
anesthetized with isoflurane and decapitated. Tissues were removed and stored at − 80 °C for future use. P42 mice 
were deeply anesthetized with 100 mg/kg ketamine and 10 mg/kg xylazine, the carotid artery was pierced and 
blood collected and the mouse was subsequently transcardially perfused with phosphate buffered saline (PBS; 
137 mM NaCl, 2.7 mM KCl, pH 7.4). Unless otherwise stated, tissues were removed, flash frozen on dry ice, and 
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stored at − 80 °C for future use. Blood was allowed to clot at room temperature for 15 minutes, centrifuged at 
2,000 × g for 10 minutes at 4 °C and the serum stored at − 80 °C for future use.
For histology, P42 WT and C/C mice were weighed, deeply anesthetized with 100 mg/kg ketamine and 10 mg/
kg xylazine and transcardially perfused with PBS followed by 4% paraformaldehyde (pH 7.4). After perfusion, 
the sex organs were removed, weighed with an analytical balance (Ohaus) and post-fixed overnight in modified 
Davidson’s fixative (Electron Microscopy Diatome) at 4 °C. Organs were processed, embedded in paraffin, sec-
tioned and stained with hematoxylin and eosin (H&E).
Histological analysis of tissue. H&E stained sections were analyzed by a board-certified Veterinary 
Pathologist to determine any pathological changes. Photographs of sections were taken with a Nikon microscope 
with SPOT Advanced software (Diagnostic Imaging, Inc.).
We utilized a previously published 10-point scoring system to assess the progression of spermatogenesis 
within the seminiferous tubules13. Twenty seminiferous tubules from all areas of each testis were scored. The 
pathologist was blinded as to genotype of each sample. The scoring system is as follows:
1 - No cells in tubular cross section.
2 - Sertoli cells only.
3 - Only spermatogonia present.
4 - No spermatozoa, no spermatids, but fewer than 5 spermatocytes present.
5 - No spermatozoa, no spermatids, but many spermatocytes present.
6 - No spermatozoa, but fewer than 5-10 spermatids present.
7 - No spermatozoa, but many spermatids present.
8 - All stages of spermatogenesis present, but fewer than 5–10 spermatozoa.
9 -  Many spermatozoa present, but germinal epithelium disorganized with marked sloughing or obliteration 
of lumen.
10 - Complete spermatogenesis.
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. Three-μ m 
formalin-fixed paraffin-embedded testis cross sections from P42 mice were subjected to TUNEL staining with 
the In situ Cell Death Detection Assay, Fluorescein (Roche) following the manufacturer’s protocol. For the neg-
ative control, two slides were incubated with only Labeling Solution (no enzyme). For the positive control, one 
slide was incubated with 2 U/μ l DNase I, recombinant (Roche) for 10 minutes at room temperature to induce 
DNA fragmentation and then incubated as per the kit protocol. After labeling, sections were coverslipped with 
VectaShield Mounting Medium with DAPI (Vectastain) and imaged. Eight to ten micrographs from all regions of 
the testis were captured for analysis. TUNEL positive bodies were counted in at least 50 tubules from all regions 
of the testis for quantification.
Immunohistochemistry. Three-μ m formalin-fixed paraffin-embedded testis cross sections from P42 mice 
were deparaffinized in xylene and rehydrated to distilled water. The sections were subjected to antigen retrieval 
for 30 minutes at 95 °C in antigen retrieval buffer (10 mM sodium citrate, 0.05% Tween-20, pH 6.0). The sections 
were then incubated in 0.3% hydrogen peroxide (Fisher) for 30 minutes to block endogenous peroxidase activity. 
Immunostaining was performed using the VECTASTAIN Elite ABC kit (Vector Laboratories) following the man-
ufacturer’s protocol. The primary antibody, rabbit anti-cleaved caspase 3 (Cell Signaling; 9661) was diluted 1:100 
and incubated with sections for 90 minutes at room temperature. Detection was performed using the ImmPACT 
DAB substrate (Vector Laboratories). Slides were subsequently stained with modified Mayer’s hematoxylin 
(Fisher), dehydrated in an ethanol gradient, coverslipped with Permount (Fisher) and imaged.
Testosterone enzyme linked immunosorbent assay (ELISA). Total serum testosterone was meas-
ured using the Mouse/Rat Testosterone ELISA kit (CalBiotech) using the manufacturer’s instructions. A standard 
curve was constructed using GraphPad Prism v6.0 using a sigmoidal 4-parameter logistics fit and testosterone 
concentration (ng/ml) were determined based on this curve.
Protein isolation. Tissue was homogenized in ten volumes radioimmunoprecipitation assay (RIPA) buffer 
(Boston Biotechnologies) with 1X HALT protease inhibitor (Thermo Fisher Scientific). The tissue was sonicated 
on ice three times for 10 seconds each with one minute between pulses at speed 2 with a Microson Ultrasonic 
Cell Disruptor (Misonix). The homogenate was incubated on ice for 30 minutes, centrifuged at 12,000 rpm for 
15 minutes at 4 °C and the supernatant transferred to a new tube. If the supernatant still appeared cloudy after 
centrifugation, the previous step was repeated. Protein concentration was determined with the BioRad Protein 
Assay. For immature (P7-P30) testes, tissue was homogenized in a glass tissue grinder (Wheaton), then processed 
the same as above, omitting the sonication step.
Immunoblotting, silver staining, and densitometric analysis. Protein lysates were diluted with 2X 
Laemmli sample buffer (BioRad) with 10% β -mercaptoethanol (Sigma-Aldrich). Samples were boiled for 10 min-
utes and then centrifuged at maximum speed for 5 minutes at room temperature. Different amounts of protein 
were loaded depending on the tissues: 12.5–15 μ g for testis, 30 μ g for uterus/ovaries and brain, 50 μ g for liver 
and 75 μ g for heart. For silver staining, protein was separated on 10% SDS-PAGE gels and then stained with the 
BioRad Silver Stain Plus kit according to the manufacturer’s protocol. For western blotting, protein was sepa-
rated on 10% SDS-PAGE gels and then transferred to Immobilon polyvinylidene fluoride (PVDF) membrane 
(Millipore) using the Turbo Transfer system (BioRad). Membranes were briefly washed in 1X Tris-buffered saline 
with Tween 20 (TBST; 50 mM Tris, 150 mM NaCl, 0.05% Tween-20, pH 7.4), and then incubated in 5% nonfat 
milk prepared in TBST. Membranes were then incubated in the appropriate primary antibody diluted in 5% milk: 
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mouse anti-SMN (BD Biosciences; 610646) diluted 1:2,000 (for heart, liver, and uterus/ovaries) or 1:5,000 (for tes-
tes), mouse anti-Gemin2 (Clone 2E17; Sigma G6669) diluted 1:500; mouse anti-hnRNPA1 (Clone 9H19; Abcam; 
ab5832) diluted 1:10,000; mouse anti-hnRNPA2/B1 (Abcam; ab6102) diluted 1:1,000; mouse anti-hnRNP Q 
(Sigma; R6353) diluted 1:800; goat anti-Tra2β (Abcam; ab31353) diluted 1:1,000; or rabbit anti-Actin (Sigma; 
A2066) diluted 1:2,000. Incubations were performed overnight at 4 °C with shaking, except anti-Actin, which was 
incubated for 1 hour at room temperature. Blots were then washed three times in TBST for at least 10 minutes 
with shaking and incubated in the appropriate secondary antibody: goat anti-mouse IgG, goat anti-rabbit IgG 
or donkey anti-goat IgG all conjugated to horseradish peroxidase (HRP) for 1 hour at room temperature or for 
30 minutes at 37˚C with shaking. Blots were then developed with either Clarity HRP substrate (BioRad) or West 
Femto substrate (Thermo Scientific Pierce) and visualized with the BioSpectrum AC Imaging System (UVP). For 
each blot, the mean intensity of each band was determined using ImageJ software. For each sample, the mean 
intensity of the protein of interest was divided by the mean intensity of Actin. For direct comparisons between 
WT and C/C, the WT average was set at 1.0 and all other samples were expressed relative to this value. For all 
time-course experiments within a genotype, the maximum expression was set at 1.0 and all other samples were 
expressed relative to this value.
Deep sequencing and analysis of C/C transcriptome. RNA was isolated from P42 testes, liver, and 
brain (n = 4 WT, n = 3 C/C for testis, n = 2 males, 2 females per genotype for liver and brain) using Trizol reagent 
according to the manufacturer’s instructions. The isolated RNA was quantified using a UV spectrophotometer 
and 10 μ g of total RNA was subjected to digestion with RQ1 RNase-free DNase (Promega). After DNase treat-
ment, the RNA was repurified using phenol:chloroform extraction followed by ethanol precipitation. Quality and 
quantity of samples was assessed on an Agilent bioanalyzer using an RNA Nano chip (Agilent). 300 ng of RNA 
was used as input for poly(A) + RNA enrichment using the NEBNext poly(A) mRNA Magnetic Isolation Module 
(New England Biolabs) and RNA-Seq libraries were generated using the NEBNext Ultra Directional RNA Library 
Prep Kit (New England Biolabs). During library preparation, barcode sequences were introduced for identifying 
sequences from each biological replicate and 6–7 libraries were pooled and run per lane on an Illumina HiSeq 
2500 using a 100-cycle single-end program.
After sequencing, contaminating adapter sequences and low-quality ends were removed using the cutadapt 
program66. After trimming, reads were mapped to the mouse genome (version GRm38/mm10) using Tophat67. 
For transcript identification, the Gencode annotation was used (http://www.gencodegenes.org/). In order to 
identify differentially regulated transcripts, read counts were obtained for all Gencode annotated genes using 
HTSeq-count68 and altered expression levels were tested using the DESeq package implemented in R69. GO term 
and KEGG pathway analysis were performed using the WebGESTALT web server (http://bioinfo.vanderbilt.edu/
webgestalt/). Candidate alternatively spliced exons were identified using MATS70.
Quantitative PCR and semi-quantitative RT-PCR. RNA was isolated from testes using the same pro-
tocol as total RNA extraction used for deep sequencing, except 30 μ g of RNA was used for DNase treatment 
and cleanup was performed on RNeasy columns (Qiagen). 2.5 μ g of total RNA was converted to cDNA using 
SuperScript III reverse transcriptase (Life Technologies) using random primers (Promega). For quantitative PCR, 
1.5 μ l of a 1:20 dilution of cDNA (equivalent to cDNA produced from 9.375 ng of RNA) was used as template in a 
20 μ l reaction containing 300 nM forward and reverse primers and 1X FastStart Universal SYBR Green Master con-
taining ROX reference dye (Roche). QPCR was performed using a Stratagene MX3005P thermocycler (Agilent) 
and relative expression levels were determined using the Δ Δ Ct method using β -Actin as a reference gene. For 
comparisons in adult tissues, values are expressed as relative to WT average. For time-course experiments, val-
ues are expressed as relative to WT average at P7. MESDA was performed as described previously14. For other 
semi-quantitative PCR reactions, 0.5 μ l of cDNA was used per 20 μ l PCR reaction using Taq polymerase (New 
England Biolabs) in the presence of 0.8–1.2 μ Ci of [α -32P] dATP. 6 μ l of PCR product was separated on a 5% (for 
MESDA) or 8% (for other semi-quantitative PCR) TBE polyacrylamide gel, dried, and exposed to a phosphorim-
ager screen. Gel images were scanned using a Fujifilm FLA-5100 and densitometric quantification was carried 
out using Multi Gauge software (Fujifilm). For all reactions labeled with [α -32P] dATP, values were corrected by 
dividing by the number of A/T base pairs in the product. All primer sequences appear in Supplementary Table 6.
Statistical analysis. Statistical analysis was performed with GraphPad software. All data are presented as 
mean ± standard error of the mean (S.E.M.) unless otherwise stated. Data on sex organ weights, sperm count, fer-
tility, TUNEL staining, and protein densitometry were analyzed with two-tailed unpaired Student’s t test. QPCR 
results were analyzed with unpaired two-tailed unpaired Student’s t test with multiple hypothesis correction using 
the Benjamimi and Hochberg method. Seminiferous tubule score means were analyzed with the Mann-Whitney 
U test. For all statistical analyses, p < 0.05 was considered significant.
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